InspireMD appoints Michael Lawless as CFO, succeeding Craig Shore

InspireMD, Inc.

Michael Lawless appointed CFO effective on/before June 30, 2025; succeeds Craig Shore who served ~15 years.
Base salary of $375,000 annually, plus performance bonus up to 50% of base salary.
Inducement grant: 212,000 stock options and 465,000 restricted shares, vesting over 3 years under NASDAQ Rule 5635(c)(4).
Employment agreement has 3-year initial term with automatic renewal; severance includes 6 months base salary (non-CIC) or 12 months (CIC).
Lawless previously CFO of Lifeward (LFWD) and held senior finance roles at Azenta, PerkinElmer, and Momenta Pharmaceuticals.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Lawless

Chief Financial Officer

NSPR · InspireMD, Inc.

Effective: 2025-06-30
Filed: Jun 03, 2025 23:59 UTC

On June 2, 2025, InspireMD, Inc. (the “ Company ”) appointed Michael Lawless as Chief Financial Officer of the Company, effective on or before June 30, 2025 (the “ Effective Date ”).

Departed

Craig Shore

Chief Financial Officer

NSPR · InspireMD, Inc.

Effective: 2025-06-30
Successor: Michael Lawless
Filed: Jun 03, 2025 23:59 UTC

On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company’s Chief Financial Officer will be terminated simultaneous with Mr. Lawless’s appointment.

Source: SEC EDGAR

accession 0001641172-25-013433

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.